<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320676">
  <stage>Registered</stage>
  <submitdate>2/10/2009</submitdate>
  <approvaldate>7/10/2009</approvaldate>
  <actrnumber>ACTRN12609000877280</actrnumber>
  <trial_identification>
    <studytitle>Development of Magnetic Resonance Imaging - Positron Emission Tomography (MRI-PET) Image Biomarkers for Brain Tumour Grading, Delineation and Measuring Early Treatment Response</studytitle>
    <scientifictitle>Development of Magnetic Resonance Imaging - Positron Emission Tomography (MRI-PET) Image Biomarkers for Brain Tumour Grading, Delineation and Measuring Early Treatment Response</scientifictitle>
    <utrn>U1111-1111-0530</utrn>
    <trialacronym>FDOPA PET - MRI</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Brain Tumour</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Brain</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>3,4-dihydroxy-6-fluoro-phenylalanine(FDOPA) PET - MRI
Brain tumour patients will be observed from diagnosis until 12 months post treatment</interventions>
    <comparator>FDOPA PET scans are not standard practice for brain tumour patients.
Standard practice is to use MRI scans to assist with diagnosis and monitor the effect of treatment.
This clinical trial will use MRI scans with the addition of FDOPA PET scans.
Historical comparisons with data stored on University of Queensland Brain Tumour MRI database (1/5/07 - 1/10/09)</comparator>
    <control>Historical</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Develop new, more sensitive PET and MRI measures for detecting early treatment response.
Historical comparisons with data stored on University of Queensland Brain Tumour MRI database (1/5/07 - 1/10/09)</outcome>
      <timepoint>12 months after study entry.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Use advanced MRI methods and PET markers and computer analysis to determine tumour response to treatment.</outcome>
      <timepoint>12 monthe after study entry.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Brain tumour</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to have standard clinical practice MRI or clinical trial FDOPA PET</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Both</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/07/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>4029</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Queensland</primarysponsorname>
    <primarysponsoraddress>The School of Information Technology and Electrical Engineering
The University of Queensland
St Lucia QLD 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Smart State Innovation Fund Program</fundingname>
      <fundingaddress>c/o: Prof Stuart Crozier
The School of Information Technology and Electrical Engineering
The University of Queensland
St Lucia QLD 4072</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Royal Brisbane and Women's Hospital</othercollaboratorname>
      <othercollaboratoraddress>Royal Brisbane and Women's Hospital
Butterfield St
Herston QLD 4029</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Eligible patients - brain tumour
Aim - to develop new, more sensitive  Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) measures for detecting early treatment response
Treated as per standard practice with the addition of 3 3,4-dihydroxy-6-fluoro-phenylalanine (FDOPA) PET scans.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane and Women's Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Royal Brisbane and Women's Hospital
Butterfield St
Herston QLD 4029</ethicaddress>
      <ethicapprovaldate>15/04/2009</ethicapprovaldate>
      <hrec>HREC/09/QRBW/18</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Stuart Crozier</name>
      <address>The School of Information Technology and Electrical Engineering
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3365 7098</phone>
      <fax />
      <email>stuart@itee.uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Pierrick Bourgeat</name>
      <address>UQ CCR Building 71/918
Butterfield St
Royal Brisbane and Women's Hospital
Herston QLD 4029</address>
      <phone>+ 61 7 3253 3659</phone>
      <fax />
      <email>Pierrick.Bourgeat@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>